Mobile

Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01039038

  • | Pays :
  • France
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The objective of the trial is to evaluating the feasibility of dose increase by a boost of curietherapy in PDR (at least 40 Gy on D95) associated to extern radiotherapy (34 Gy) in intermediate risk in prostate cancer.

Critère d'inclusion

  • Prostate Cancer With Intermediate Risk

Liens